Clinical Trials Directory

Trials / Unknown

UnknownNCT04734912

Evaluation of Transnasal Endoscopy During COVID-19 Pandemic

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
500 (estimated)
Sponsor
Johannes Gutenberg University Mainz · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

Patients who received the indication for endoscopic diagnostics using gastroscopy in transnasal technique will be included into the study. The examination is carried out in standard technique and is not influenced by the study. Following the examination, patient data is collected pseudonymously and a questionnaire is submitted to the patient.

Detailed description

COVID-19 is transmitted, among other things, by a droplet infection. Conventional gastroscopy through the patient's mouth is therefore considered a high-risk examination for the medical and nursing staff. Alternatively, gastroscopy can also be performed through the patient's nose. An advantage here is that the aerosol formation is naturally significantly reduced and the patient usually does not need sedation, since in transnasal endoscopy no stranglehold occurs. Transnasal endoscopy therefore appears to us, especially during the COVID-19 pandemic, as a safe alternative to conventional gastroscopy. Patients who received the indication for endoscopic diagnostics using gastroscopy in transnasal technique will be included into the study. The examination is carried out in standard technique and is not influenced by the study. Following the examination, patient data is collected pseudonymously and a questionnaire is sumbitted to the patient. Only patients who have the indication for gastroscopy in transnasal technique are included. A specific risk to patients cannot be foreseen.This study does not interfere with diagnostics or therapy.

Conditions

Interventions

TypeNameDescription
OTHERgastroscopy in transnasal techiqueAll patients with indication for gastroscopy in transnasal technique are included.

Timeline

Start date
2021-01-13
Primary completion
2021-06-15
Completion
2021-12-31
First posted
2021-02-02
Last updated
2021-02-02

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT04734912. Inclusion in this directory is not an endorsement.